I agree that this site is using cookies. You can find further informations here.
X
Callaghan, Michael U
1311  results:
Search for persons X
?
1

Effects of PK‐guided prophylaxis on clinical outcomes and F..:

Young, Guy ; Callaghan, Michael U. ; Balasa, Vinod...
Haemophilia.  29 (2023)  5 - p. 1234-1242 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Consensus definition of essential, optimal, and suggested c..:

Hulbert, Monica L. ; Manwani, Deepa ; Meier, Emily Riehm...
Pediatric Blood & Cancer.  70 (2022)  1 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
3

Targeting TRPV1 activity via high‐dose capsaicin in patient..:

Glaros, Alexander K. ; Callaghan, Michael U. ; Smith, Wally R..
eJHaem.  3 (2022)  3 - p. 653-659 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Prophylactic Hydroxyurea Treatment Is Associated with Impro..:

Peine, Brian R. ; Callaghan, Michael U. ; Callaghan, Joseph H..
Journal of Clinical Medicine.  11 (2022)  12 - p. 3491 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Untreated bleeds in people with hemophilia A in a noninterv..:

Callaghan, Michael U. ; Asikanius, Elina ; Lehle, Michaela...
Research and Practice in Thrombosis and Haemostasis.  6 (2022)  6 - p. e12782 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Managing Severe Hemophilia A in Children: Pharmacotherapeut..:

Regling, Katherine ; Callaghan, Michael U ; Sidonio Jr, Robert
Pediatric Health, Medicine and Therapeutics.  13 (2022)  - p. 27-35 , 2022
Link: https://doi.org/10.2147/..
 
?
7

Discussing investigational AAV gene therapy with hemophilia..:

Sidonio Jr, Robert F. ; Pipe, Steven W. ; Callaghan, Michael U....
Blood Reviews.  47 (2021)  - p. 100759 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Longitudinal assessment of adhesion to vascular cell adhesi..:

White, Jennell ; Callaghan, Michael U. ; Gao, Xiufeng...
British Journal of Haematology.  196 (2021)  4 - p. 1052-1058 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Clinical predictors of poor outcomes in patients with sickl..:

Minniti, Caterina P. ; Zaidi, Ahmar U. ; Nouraie, Mehdi...
Blood Advances.  5 (2021)  1 - p. 207-215 , 2021
Link: https://doi.org/10.1182/..
 
?
10

The effect of emicizumab prophylaxis on long‐term, self‐rep..:

Skinner, Mark W. ; Négrier, Claude ; Paz‐Priel, Ido...
Haemophilia.  27 (2021)  5 - p. 854-865 , 2021
Link: https://doi.org/10.1111/..
 
?
11

Flow adhesion of whole blood to P‐selectin: a prognostic bi..:

Hines, Patrick C. ; Callaghan, Michael U. ; Zaidi, Ahmar U....
British Journal of Haematology.  194 (2021)  6 - p. 1074-1082 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Pharmacokinetics and Pharmacodynamics of Emicizumab in Pers..:

Schmitt, Christophe ; Adamkewicz, Joanne I. ; Xu, Jin...
Thrombosis and Haemostasis.  121 (2020)  3 - p. 351-360 , 2020
Link: https://doi.org/10.1055/..
 
?
13

Spontaneous bleeding and poor bleeding response with extend..:

Malec, Lynn M. ; Croteau, Stacy E. ; Callaghan, Michael U..
Haemophilia.  26 (2020)  3 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
14

Bortezomib treatment of steroid‐refractory Evans syndrome i..:

Beydoun, Serina B. ; Persaud, Yogindra ; Lafferty, Jennifer..
Pediatric Blood & Cancer.  67 (2020)  12 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
15

Concurrent homozygous sickle‐cell disease and severe haemop..:

Zaidi, Ahmar U. ; Rao, Latha ; Callaghan, Michael U....
Haemophilia.  25 (2019)  2 - p. , 2019
Link: https://doi.org/10.1111/..
 
1-15